Global Finasteride Oral Tablet Market

Market Size in USD Billion

CAGR : 17.60%

USD 1.14

2025

USD 4.17

2033

Forecast Period	2025 - 2033
Market Size (Base Year)	USD 1.14 Billion
Market Size (Forecast)	USD 4.17 Billion
CAGR	17.60%
Major Market Players	Data provided in full report

A research report on the Finasteride Oral Tablet market by Extent Research provides the vital information associated with the market growth during the forecast timeframe. The document also covers information such as historical, current, and future growth rate and finances in order to help other companies gain better knowledge about the Finasteride Oral Tablet market. The report offers elaborative data that will provide insights of competitive market status and what the future holds. In addition to all this, the Finasteride Oral Tablet market report encompasses market analysis data based on region, company profile, application, distribution channel, and others.

Data provided by Extent Research. Source: https://www.extentresearch.com/finasteride-oral-tablet-market

The study report on global Finasteride Oral Tablet market covers the regions that have the industry flourishing. Also, the market size, share, revenue, opportunities, challenges, and import/export analysis are accurately mentioned to get a clear picture about the future growth rate. The regions covered include North America, Europe, Asia Pacific, Latin America, Middle East & Africa. There are valuable insights of the market coupled with the strategic plans that undoubtedly will help the Finasteride Oral Tablet business expand and penetrate further into the market.

The competitive players Merck, Accord Healthcare UK, Relonchem, Sandoz, Teva Generics, Cipla, Dr. Reddy, Aurobindo Pharma, Henan Topfond, Zhejiang CONBA Pharmaceutical, Shandong Renhetang Pharmaceutical, Guangdong Eashu Pharmacetical, Shanghai Shyndec Pharmaceutical Co.,Ltd., are well analyzed to provide advantages of the various business strategies, government policies, technological advancements, and new product launches on the Finasteride Oral Tablet market. Like any other report, this report focuses on the industry sales, share, revenue, threats, and opportunities to expand in various regions across the globe. In the end, Finasteride Oral Tablet market report delivers a conclusion that includes consumer preferences or needs, estimated market size, market analysis, and other factors likely to enhance the business overall.

Segmentation of the Global Finasteride Oral Tablet Market:

By Product type

1mg Tablet, 5mg Tablet,

by Application

Benign Prostatic Hyperplasia, Male Pattern Baldness, Others,

Report provides answers for the following:

Which are the key market players in the Finasteride Oral Tablet industry?
What the strategies followed by key players to combat this covid-19 event?
What is expected growth rate of the global Finasteride Oral Tablet market during the forecast period?
What will be the estimated value of Finasteride Oral Tablet market in the during the forecast period?
What are opportunities, challenges, and threats the market will face to survive?

Report Scope and Market Segmentation

ATTRIBUTES	Global Finasteride Oral Tablet Market KEY MARKET INSIGHTS
Segments Covered	By Product Type: All Products Type Includes By Application: All Application Type Includes By End User: All End User Type Includes By Distribution Channel: All Distribution Channel Includes
Countries Covered	North America U.S., Canada, Mexico Europe Germany, United Kingdom, France, Italy, Spain, Nordic Countries, Benelux Union, Rest of Europe Asia-Pacific China, India, Japan, New Zealand, South Korea, Australia, Southeast Asia, Rest of Asia Pacific Latin America Brazil, Argentina, Rest of Latin America Middle East & Africa Saudi Arabia, UAE, Egypt, Kuwait, South Africa, Rest of Middle East & Africa
Key Market Players	Leading Tier 1 Corporations Prominent Regional Manufacturers Emerging Market Disruptors Technology Integrators & Suppliers *Complete vendor layout of 15+ major players provided in the final report.
Market Opportunities	Market Size and Growth: Quantifying the total addressable market (TAM) and projected growth rates to assess financial viability. Customer Segmentation: Identifying target audience behaviors, pain points, and specific unfulfilled demands. Competitive Landscape: Analyzing existing competitors' strengths, weaknesses, and market share to pinpoint gaps and opportunities. Industry Trends: Mapping technological, regulatory, and economic shifts that create favorable conditions for market entry. Risk Assessment: Evaluating barriers to entry and operational challenges alongside strategic roadmaps for mitigation.
Value Added Data Infosets	In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by our expert team also include in-depth expert analysis, geographically represented company-wise production and capacity, network layouts of distributors and partners, detailed and updated price trend analysis and deficit analysis of supply chain and demand.

Meet the Team

Julie

Author

Julie Jayne is a distinguished multidisciplinary strategist and the Head of Research at Extent Research, where she leverages over a decade of comprehensive experience in the global market intelligence industry. Backed by a robust academic foundation that includes a B.Sc. and an MBA, she perfectly...

Priya M

Reviewed By

With over 14 years of dedicated professional expertise in business-to-business (B2B) intelligence, Priya M stands as a distinguished leader in corporate strategy, revenue growth, and advanced data analysis. Her dynamic career is defined by a relentless focus on mitigating business risks and empowering corporate executives...

Learn more about Priya M

BASIC ATTRIBUTES \| KEY MARKET INSIGHTS
Report Title	Global Finasteride Oral Tablet Market
Base Year	2025
Forecast Period	2025 - 2033
Market Size (Base)	USD 1.14 Billion
Projected Size	USD 4.17 Billion
CAGR	17.60%

                            1 Finasteride Oral Tablet Market Overview
    1.1 Product Overview and Scope of Finasteride Oral Tablet
    1.2 Finasteride Oral Tablet Segment by Type
        1.2.1 Global Finasteride Oral Tablet Sales Growth Rate Comparison by Type (2022-2035)
        1.2.2 1mg Tablet
        1.2.3 5mg Tablet
    1.3 Finasteride Oral Tablet Segment by Application
        1.3.1 Global Finasteride Oral Tablet Sales Comparison by Application: (2022-2035)
        1.3.2 Benign Prostatic Hyperplasia
        1.3.3 Male Pattern Baldness
        1.3.4 Others
    1.4 Global Finasteride Oral Tablet Market Size Estimates and Forecasts
        1.4.1 Global Finasteride Oral Tablet Revenue 2017-2035
        1.4.2 Global Finasteride Oral Tablet Sales 2017-2035
        1.4.3 Finasteride Oral Tablet Market Size by Region: 2017 Versus 2021 Versus 2035
2 Finasteride Oral Tablet Market Competition by Manufacturers
    2.1 Global Finasteride Oral Tablet Sales Market Share by Manufacturers (2017-2022)
    2.2 Global Finasteride Oral Tablet Revenue Market Share by Manufacturers (2017-2022)
    2.3 Global Finasteride Oral Tablet Average Price by Manufacturers (2017-2022)
    2.4 Manufacturers Finasteride Oral Tablet Manufacturing Sites, Area Served, Product Type
    2.5 Finasteride Oral Tablet Market Competitive Situation and Trends
        2.5.1 Finasteride Oral Tablet Market Concentration Rate
        2.5.2 The Global Top 5 and Top 10 Largest Finasteride Oral Tablet Players Market Share by Revenue
        2.5.3 Global Finasteride Oral Tablet Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Finasteride Oral Tablet Retrospective Market Scenario by Region
    3.1 Global Finasteride Oral Tablet Retrospective Market Scenario in Sales by Region: 2017-2022
    3.2 Global Finasteride Oral Tablet Retrospective Market Scenario in Revenue by Region: 2017-2022
    3.3 North America Finasteride Oral Tablet Market Facts & Figures by Country
        3.3.1 North America Finasteride Oral Tablet Sales by Country
        3.3.2 North America Finasteride Oral Tablet Revenue by Country
        3.3.3 United States
        3.3.4 Canada
    3.4 Europe Finasteride Oral Tablet Market Facts & Figures by Country
        3.4.1 Europe Finasteride Oral Tablet Sales by Country
        3.4.2 Europe Finasteride Oral Tablet Revenue by Country
        3.4.3 Germany
        3.4.4 France
        3.4.5 U.K.
        3.4.6 Italy
        3.4.7 Russia
    3.5 Asia Pacific Finasteride Oral Tablet Market Facts & Figures by Region
        3.5.1 Asia Pacific Finasteride Oral Tablet Sales by Region
        3.5.2 Asia Pacific Finasteride Oral Tablet Revenue by Region
        3.5.3 China
        3.5.4 Japan
        3.5.5 South Korea
        3.5.6 India
        3.5.7 Australia
        3.5.8 China Taiwan
        3.5.9 Indonesia
        3.5.10 Thailand
        3.5.11 Malaysia
    3.6 Latin America Finasteride Oral Tablet Market Facts & Figures by Country
        3.6.1 Latin America Finasteride Oral Tablet Sales by Country
        3.6.2 Latin America Finasteride Oral Tablet Revenue by Country
        3.6.3 Mexico
        3.6.4 Brazil
        3.6.5 Argentina
    3.7 Middle East and Africa Finasteride Oral Tablet Market Facts & Figures by Country
        3.7.1 Middle East and Africa Finasteride Oral Tablet Sales by Country
        3.7.2 Middle East and Africa Finasteride Oral Tablet Revenue by Country
        3.7.3 Turkey
        3.7.4 Saudi Arabia
        3.7.5 UAE
4 Global Finasteride Oral Tablet Historic Market Analysis by Type
    4.1 Global Finasteride Oral Tablet Sales Market Share by Type (2017-2022)
    4.2 Global Finasteride Oral Tablet Revenue Market Share by Type (2017-2022)
    4.3 Global Finasteride Oral Tablet Price by Type (2017-2022)
5 Global Finasteride Oral Tablet Historic Market Analysis by Application
    5.1 Global Finasteride Oral Tablet Sales Market Share by Application (2017-2022)
    5.2 Global Finasteride Oral Tablet Revenue Market Share by Application (2017-2022)
    5.3 Global Finasteride Oral Tablet Price by Application (2017-2022)
6 Key Companies Profiled
    6.1 Merck
        6.1.1 Merck Corporation Information
        6.1.2 Merck Description and Business Overview
        6.1.3 Merck Finasteride Oral Tablet Sales, Revenue and Gross Margin (2017-2022)
        6.1.4 Merck Finasteride Oral Tablet Product Portfolio
        6.1.5 Merck Recent Developments/Updates
    6.2 Accord Healthcare UK
        6.2.1 Accord Healthcare UK Corporation Information
        6.2.2 Accord Healthcare UK Description and Business Overview
        6.2.3 Accord Healthcare UK Finasteride Oral Tablet Sales, Revenue and Gross Margin (2017-2022)
        6.2.4 Accord Healthcare UK Finasteride Oral Tablet Product Portfolio
        6.2.5 Accord Healthcare UK Recent Developments/Updates
    6.3 Relonchem
        6.3.1 Relonchem Corporation Information
        6.3.2 Relonchem Description and Business Overview
        6.3.3 Relonchem Finasteride Oral Tablet Sales, Revenue and Gross Margin (2017-2022)
        6.3.4 Relonchem Finasteride Oral Tablet Product Portfolio
        6.3.5 Relonchem Recent Developments/Updates
    6.4 Sandoz
        6.4.1 Sandoz Corporation Information
        6.4.2 Sandoz Description and Business Overview
        6.4.3 Sandoz Finasteride Oral Tablet Sales, Revenue and Gross Margin (2017-2022)
        6.4.4 Sandoz Finasteride Oral Tablet Product Portfolio
        6.4.5 Sandoz Recent Developments/Updates
    6.5 Teva Generics
        6.5.1 Teva Generics Corporation Information
        6.5.2 Teva Generics Description and Business Overview
        6.5.3 Teva Generics Finasteride Oral Tablet Sales, Revenue and Gross Margin (2017-2022)
        6.5.4 Teva Generics Finasteride Oral Tablet Product Portfolio
        6.5.5 Teva Generics Recent Developments/Updates
    6.6 Cipla
        6.6.1 Cipla Corporation Information
        6.6.2 Cipla Description and Business Overview
        6.6.3 Cipla Finasteride Oral Tablet Sales, Revenue and Gross Margin (2017-2022)
        6.6.4 Cipla Finasteride Oral Tablet Product Portfolio
        6.6.5 Cipla Recent Developments/Updates
    6.7 Dr. Reddy
        6.6.1 Dr. Reddy Corporation Information
        6.6.2 Dr. Reddy Description and Business Overview
        6.6.3 Dr. Reddy Finasteride Oral Tablet Sales, Revenue and Gross Margin (2017-2022)
        6.4.4 Dr. Reddy Finasteride Oral Tablet Product Portfolio
        6.7.5 Dr. Reddy Recent Developments/Updates
    6.8 Aurobindo Pharma
        6.8.1 Aurobindo Pharma Corporation Information
        6.8.2 Aurobindo Pharma Description and Business Overview
        6.8.3 Aurobindo Pharma Finasteride Oral Tablet Sales, Revenue and Gross Margin (2017-2022)
        6.8.4 Aurobindo Pharma Finasteride Oral Tablet Product Portfolio
        6.8.5 Aurobindo Pharma Recent Developments/Updates
    6.9 Henan Topfond
        6.9.1 Henan Topfond Corporation Information
        6.9.2 Henan Topfond Description and Business Overview
        6.9.3 Henan Topfond Finasteride Oral Tablet Sales, Revenue and Gross Margin (2017-2022)
        6.9.4 Henan Topfond Finasteride Oral Tablet Product Portfolio
        6.9.5 Henan Topfond Recent Developments/Updates
    6.10 Zhejiang CONBA Pharmaceutical
        6.10.1 Zhejiang CONBA Pharmaceutical Corporation Information
        6.10.2 Zhejiang CONBA Pharmaceutical Description and Business Overview
        6.10.3 Zhejiang CONBA Pharmaceutical Finasteride Oral Tablet Sales, Revenue and Gross Margin (2017-2022)
        6.10.4 Zhejiang CONBA Pharmaceutical Finasteride Oral Tablet Product Portfolio
        6.10.5 Zhejiang CONBA Pharmaceutical Recent Developments/Updates
    6.11 Shandong Renhetang Pharmaceutical
        6.11.1 Shandong Renhetang Pharmaceutical Corporation Information
        6.11.2 Shandong Renhetang Pharmaceutical Finasteride Oral Tablet Description and Business Overview
        6.11.3 Shandong Renhetang Pharmaceutical Finasteride Oral Tablet Sales, Revenue and Gross Margin (2017-2022)
        6.11.4 Shandong Renhetang Pharmaceutical Finasteride Oral Tablet Product Portfolio
        6.11.5 Shandong Renhetang Pharmaceutical Recent Developments/Updates
    6.12 Guangdong Eashu Pharmacetical
        6.12.1 Guangdong Eashu Pharmacetical Corporation Information
        6.12.2 Guangdong Eashu Pharmacetical Finasteride Oral Tablet Description and Business Overview
        6.12.3 Guangdong Eashu Pharmacetical Finasteride Oral Tablet Sales, Revenue and Gross Margin (2017-2022)
        6.12.4 Guangdong Eashu Pharmacetical Finasteride Oral Tablet Product Portfolio
        6.12.5 Guangdong Eashu Pharmacetical Recent Developments/Updates
    6.13 Shanghai Shyndec Pharmaceutical Co.,Ltd.
        6.13.1 Shanghai Shyndec Pharmaceutical Co.,Ltd. Corporation Information
        6.13.2 Shanghai Shyndec Pharmaceutical Co.,Ltd. Finasteride Oral Tablet Description and Business Overview
        6.13.3 Shanghai Shyndec Pharmaceutical Co.,Ltd. Finasteride Oral Tablet Sales, Revenue and Gross Margin (2017-2022)
        6.13.4 Shanghai Shyndec Pharmaceutical Co.,Ltd. Finasteride Oral Tablet Product Portfolio
        6.13.5 Shanghai Shyndec Pharmaceutical Co.,Ltd. Recent Developments/Updates
7 Finasteride Oral Tablet Manufacturing Cost Analysis
    7.1 Finasteride Oral Tablet Key Raw Materials Analysis
       7.1.1 Key Raw Materials
       7.1.2 Key Suppliers of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
    7.3 Manufacturing Process Analysis of Finasteride Oral Tablet
    7.4 Finasteride Oral Tablet Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
    8.1 Marketing Channel
    8.2 Finasteride Oral Tablet Distributors List
    8.3 Finasteride Oral Tablet Customers
9 Finasteride Oral Tablet Market Dynamics
    9.1 Finasteride Oral Tablet Industry Trends
    9.2 Finasteride Oral Tablet Market Drivers
    9.3 Finasteride Oral Tablet Market Challenges
    9.4 Finasteride Oral Tablet Market Restraints
10 Global Market Forecast
    10.1 Finasteride Oral Tablet Market Estimates and Projections by Type
        10.1.1 Global Forecasted Sales of Finasteride Oral Tablet by Type (2023-2035)
        10.1.2 Global Forecasted Revenue of Finasteride Oral Tablet by Type (2023-2035)
    10.2 Finasteride Oral Tablet Market Estimates and Projections by Application
        10.2.1 Global Forecasted Sales of Finasteride Oral Tablet by Application (2023-2035)
        10.2.2 Global Forecasted Revenue of Finasteride Oral Tablet by Application (2023-2035)
    10.3 Finasteride Oral Tablet Market Estimates and Projections by Region
        10.3.1 Global Forecasted Sales of Finasteride Oral Tablet by Region (2023-2035)
        10.3.2 Global Forecasted Revenue of Finasteride Oral Tablet by Region (2023-2035)
11 Research Finding and Conclusion
12 Methodology and Data Source
    12.1 Methodology/Research Approach
        12.1.1 Research Programs/Design
        12.1.2 Market Size Estimation
        12.1.3 Market Breakdown and Data Triangulation
    12.2 Data Source
        12.2.1 Secondary Sources
        12.2.2 Primary Sources
    12.3 Author List
    12.4 Disclaimer                        

Research Methodology

Data collection and base year analysis are done using proprietary data collection modules with large sample sizes. The process includes obtaining market information through extensive secondary sources, paid databases, and verifying data via primary (industry expert) validation.

Our market models include Vendor Positioning Grids, Market Timeline Analysis, Company Market Share Analysis, and Top-Down/Bottom-Up forecasting models. To know more about the research methodology, drop an inquiry to speak to our industry experts.

Speak to Analyst

Global Finasteride Oral Tablet Market